Who Owns SYNDAX PHARMACEUTICALS INC (SNDX)? -- Institutional Holders (2026-06-30)

279 institutions reported holding $2.41B of SYNDAX PHARMACEUTICALS INC (SNDX) in SEC 13F filings for 2026-06-30. Largest institutional holders: BlackRock, Inc. ($197.2M), Kynam Capital Management, LP ($176.0M), VANGUARD GROUP INC ($144.2M), GOLDMAN SACHS GROUP INC ($128.1M), STATE STREET CORP ($123.7M). Source: SEC Form 13F.

Rank	Institution	Value	Shares	Change
1	BlackRock, Inc.	$197.2M	9.0M	Added
2	Kynam Capital Management, LP	$176.0M	8.1M	Hold
3	VANGUARD GROUP INC	$144.2M	6.6M	Added
4	GOLDMAN SACHS GROUP INC	$128.1M	5.9M	Added
5	STATE STREET CORP	$123.7M	5.7M	Added
6	BANK OF AMERICA CORP /DE/	$88.4M	4.0M	Trimmed
7	DEERFIELD MANAGEMENT COMPANY, L.P.	$82.6M	3.8M	Hold
8	Eversept Partners, LP	$61.2M	2.8M	Trimmed
9	GEODE CAPITAL MANAGEMENT, LLC	$56.5M	2.6M	Added
10	Hood River Capital Management LLC	$56.1M	2.6M	Added
11	KINGDON CAPITAL MANAGEMENT, L.L.C.	$54.6M	2.5M	Hold
12	FRANKLIN RESOURCES INC	$50.0M	2.3M	Added
13	MILLENNIUM MANAGEMENT LLC	$44.9M	2.1M	Added
14	SILVERARC CAPITAL MANAGEMENT, LLC	$41.7M	1.9M	Added
15	UBS Group AG	$41.4M	1.9M	Added
16	Elmind Capital, LP	$40.6M	1.9M	Hold
17	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$39.1M	1.8M	Added
18	Candriam S.C.A.	$37.0M	1.7M	Added
19	Soleus Capital Management, L.P.	$35.6M	1.6M	Trimmed
20	TWO SIGMA INVESTMENTS, LP	$34.5M	1.6M	Trimmed
21	ORBIMED ADVISORS LLC	$33.7M	1.5M	Added
22	Nuveen, LLC	$29.8M	1.4M	Trimmed
23	MPM BIOIMPACT LLC	$29.2M	1.3M	Trimmed
24	Aisling Capital Management LP	$28.8M	1.3M	Hold
25	Woodline Partners LP	$27.3M	1.3M	Hold

Source: SEC Form 13F filings · as of 2026-06-30